After images: Difference between revisions
>Kaylee wording, expanding effect |
>Josikins Grammatics |
||
Line 5: | Line 5: | ||
During [[hallucinogen|hallucinogenic]] experiences, moving objects can produce a trail of overlayed, still images behind their path of motion.<ref name="25B">Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 1-11. https://doi.org/10.1007/s11419-014-0242-9</ref><ref name="Visual_Function_1988">Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://psycnet.apa.org/doi/10.1037/0021-843X.97.4.443</ref><ref>Kawasaki, A., & Purvin, V. (1996). Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD). Archives of Ophthalmology, 114(1), 47-50. https://doi.org/10.1001/archopht.1996.01100130045007</ref><ref name="VisualPhen"/><ref name="VisualTrails">Dubois, J., & VanRullen, R. (2011). Visual trails: do the doors of perception open periodically?. PLoS biology, 9(5), e1001056. https://dx.doi.org/10.1371%2Fjournal.pbio.1001056</ref><ref>Ermentrout B. The excited cortex - LSD trails, phosphenes, and other visual confections. 1999. 201 Eighth Annual Computational Neuroscience Meeting; Pittsburgh, Pennsylvania; July 1999. Abstracts.</ref> This creates a series of overlayed images of a moving object across one's visual field which become more faded the longer the duration since the object occupied that location in space. Another common manifestation of this effect is being able to see a residual image of the external environment for several seconds after one closes their eyes before it gradually fades away. | During [[hallucinogen|hallucinogenic]] experiences, moving objects can produce a trail of overlayed, still images behind their path of motion.<ref name="25B">Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 1-11. https://doi.org/10.1007/s11419-014-0242-9</ref><ref name="Visual_Function_1988">Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://psycnet.apa.org/doi/10.1037/0021-843X.97.4.443</ref><ref>Kawasaki, A., & Purvin, V. (1996). Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD). Archives of Ophthalmology, 114(1), 47-50. https://doi.org/10.1001/archopht.1996.01100130045007</ref><ref name="VisualPhen"/><ref name="VisualTrails">Dubois, J., & VanRullen, R. (2011). Visual trails: do the doors of perception open periodically?. PLoS biology, 9(5), e1001056. https://dx.doi.org/10.1371%2Fjournal.pbio.1001056</ref><ref>Ermentrout B. The excited cortex - LSD trails, phosphenes, and other visual confections. 1999. 201 Eighth Annual Computational Neuroscience Meeting; Pittsburgh, Pennsylvania; July 1999. Abstracts.</ref> This creates a series of overlayed images of a moving object across one's visual field which become more faded the longer the duration since the object occupied that location in space. Another common manifestation of this effect is being able to see a residual image of the external environment for several seconds after one closes their eyes before it gradually fades away. | ||
After images are often accompanied by other coinciding effects such as [[tracers]]<ref name="Visual_Function_1988"/><ref>Asher, H. (1971). Trailing” phenomenon–a long-lasting LSD side effect. Am J Psychiatry, 127(9), 1233-4. https://doi.org/10.1176/ajp.127.9.1233</ref><ref>Schwartz, K. (1997). Nefazodone and visual side effects. The American journal of psychiatry, 154(7), 1038. https://www.ncbi.nlm.nih.gov/pubmed/9210763</ref> and [[drifting]].<ref name="25B"/> They are most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]].<ref>Lauterbach, E., Abdelhamid, A., & Annandale, J. B. (2000). Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsychiatry, 33(01), 38-41.https://doi.org/10.1055/s-2000-8452</ref> However, trailing effects have also been experienced with other drugs of a very different pharmacology, such as GABA potentiators.<ref name="VisualTrails"/> | After images are often accompanied by other coinciding effects such as [[tracers]]<ref name="Visual_Function_1988"/><ref>Asher, H. (1971). Trailing” phenomenon–a long-lasting LSD side effect. Am J Psychiatry, 127(9), 1233-4. https://doi.org/10.1176/ajp.127.9.1233</ref><ref>Schwartz, K. (1997). Nefazodone and visual side effects. The American journal of psychiatry, 154(7), 1038. https://www.ncbi.nlm.nih.gov/pubmed/9210763</ref> and [[drifting]].<ref name="25B"/> They are most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]].<ref>Lauterbach, E., Abdelhamid, A., & Annandale, J. B. (2000). Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsychiatry, 33(01), 38-41.https://doi.org/10.1055/s-2000-8452</ref> However, trailing effects have also been experienced with other drugs of a very different pharmacology, such as GABA potentiators.<ref name="VisualTrails"/></onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: |